Figure 7.
Impaired growth of NPM/ALK-expressing cells in vivo after Bcl-XL down-regulation.(A) Ba/F3-NPM/ALK+ cells (10 × 106) bearing an empty vector control (N/A-pEV, □) and a Dox-inducible ASBcl-XL antisense transgene (N/A-pAS, ○) were injected intravenously into nude mice. Half of the mice from each group (N/A-pEV, ▪; N/A-pAS, •) was maintained under continuous administration of doxycycline (0.2 mg/mL) in the drinking water. Survival of the animals was monitored every other day. (B) Animals injected with N/A-pEV and N/A-pAS cells and bearing measurable nodules (mean tumor weight was 235 mg; 95% confidence interval [CI] = 200-320 mg) were treated with Dox (0.2 mg/mL) in the drinking water. After 3 days of Dox treatment, mice were killed and tumors extracted and analyzed in Western blot (WB) with anti-Bcl-XL and anti-ALK antibodies.